Henning Wege

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein et al. · Journal of Hepatology · 2021 · 284 citations · Full text

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

Jan Best, Lars P. Bechmann, Jan‐Peter Sowa et al. · Clinical Gastroenterology and Hepatology · 2019 · 277 citations

Presence of EpCAM‐positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma

Kornelius Schulze, Christin Gasch, Katharina Staufer et al. · International Journal of Cancer · 2013 · 245 citations · Full text

Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial

Alexander Stein, Dirk Arnold, John Bridgewater et al. · BMC Cancer · 2015 · 226 citations · Full text